...
首页> 外文期刊>Alexandria Journal of Medicine >Serum cobalamin and red cell folate levels of anti-psychotic treatment and treatment na?ve psychiatic patients in a tertiary hospital in Nigeria
【24h】

Serum cobalamin and red cell folate levels of anti-psychotic treatment and treatment na?ve psychiatic patients in a tertiary hospital in Nigeria

机译:尼日利亚一家三级医院抗精神病药物治疗的血清钴胺素和红细胞叶酸水平及未接受过精神病治疗的患者

获取原文

摘要

BackgroundPsychiatric disorders contribute significantly to the global burden of diseases. There is an urgent need to curtail the morbidity and mortality associated with psychiatric disorders. Deficiencies of cobalamin and folate have been linked with psychiatric disorders.Materials and methodSixty-six each of antipsychotic treatment, treatment na?ve psychiatric patients and control were recruited for the study. Red cell folate and serum cobalamin were determined with Enzyme Linked Immunosorbent Assay kits and the haemogram using Sysmex XT2000i.ResultFolate deficiency was present in 13.6% of newly diagnosed anti-psychotic naive psychiatric patients with few of them having neutrophil hypersegmentation (7.6%) and macrocytosis (4.5%). Mean red cell folate levels for anti-psychotic na?ve, patients on anti-psychotic and controls were 350.23±0.54nmol/l, 370±0.70nmol/l and 370±0.51nmol/l respectively, with p-values of 0.0001 and 0.3500 respectively when compared with control, while serum cobalamin levels were within the normal reference range in all patients and controls.Reticulocyte count had 8 times and 3 times likelihood of influencing low serum folate and low serum cobalamin respectively.ConclusionAll patients had Serum cobalamin levels within the reference interval, the same can be said of the RBC folate levels of the greater percentage (95.5%) of psychiatric patients on psychotropic drugs.
机译:背景技术精神疾病极大地增加了全球疾病负担。迫切需要减少与精神疾病有关的发病率和死亡率。材料和方法钴胺素和叶酸的缺乏与精神疾病有关。材料和方法分别收集了66种抗精神病药物治疗,未接受过治疗的精神病患者和对照进行研究。使用酶联免疫吸附测定试剂盒测定红细胞叶酸和血清钴胺素,并使用Sysmex XT2000i进行血流图检查。结果在新诊断的抗精神病性幼稚精神病患者中存在叶酸缺乏症的比例为13.6%,其中很少有中性粒细胞过度分裂(7.6%)和巨噬细胞(4.5%)。抗精神病药物初次治疗,接受抗精神病药物治疗的患者和对照组的平均红细胞叶酸水平分别为350.23±0.54nmol / l,370±0.70nmol / l和370±0.51nmol / l,p值分别为0.0001和所有患者和对照组的血清钴胺素水平分别为0.3500和0.35,而网织红细胞计数分别影响低血清叶酸和低血清钴胺素的可能性分别为8倍和3倍。在参考时间间隔内,可以说相同的是,接受精神科药物治疗的精神病患者中RBC叶酸水平更高(95.5%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号